Sanofi, the Paris-based multinational pharmaceutical and healthcare company headquartered in Paris but with extensive operations in the United States, is partnering with the Howard University College of Pharmacy in a fellowship program.
The company will offer 10 new post-graduate fellowships in the College of Pharmacy for students earning pharmacy doctorates. Upon successful completion of the program, Sanofi’s goal is to hire fellows into permanent full-time positions at the company, marking the first time an industry partner with the college has committed to post-fellowship employment.
The two-year fellowship Sanofi program is part of the pharmaceutical company’s ongoing efforts to address disparities in underrepresented communities. Set to begin in the second half of 2022, the Sanofi program will allow the 10 PharmD graduates an opportunity to participate in practical learning experiences across multiple research and development fields, including oncology, rare diseases, neurology, immunology, regulatory, pharmacovigilance, and clinical operations, as well as U.S. medical, public policy and patient advocacy.
“At Sanofi, we recognize that work-force diversity correlates strongly with creativity, successful problem solving, and visionary innovation,” said John Reed, global head of research and development at Sanofi. “This collaboration with Howard University will allow us the opportunity to foster the next generation of scientists from historically underrepresented communities.”
Earl B. Ettienne, the College of Pharmacy’s director of graduate programs and industry partnerships, said the partnership reflects the college’s continued commitment to addressing real-world challenges with innovative solutions. “We pride ourselves in developing excellent men and women that are ready to contribute on day one and applaud Sanofi for joining us with a bold effort to create the next generation of leaders and researchers in the biopharmaceutical space.”